INGN FY 2021 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$358M+16.1% YoY

Gross Profit

$176M49.3% margin

Operating Income

$9M2.6% margin

Net Income

-$6M-1.8% margin

EPS (Diluted)

$-0.28

Cash Flow

Operating Cash Flow

$24M

Free Cash Flow

-$302,000

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$490M

Total Liabilities

$119M

Stockholders' Equity

$370M

Cash & Equivalents

$236M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$358M	$308M	+16.1%
Gross Profit	$176M	$138M	+27.7%
Operating Income	$9M	-$12M	+176.8%
Net Income	-$6M	-$6M	-8.6%